Close Menu

NEW YORK (360Dx) — Banyan Biomarkers announced today that it has nonexclusively licensed its proprietary blood biomarkers of traumatic brain injury (TBI) to Abbott.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.